YW9-62919-08498
2 vaccinations
4 coded responses
25 check-ins
4 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 21-25
- ZIP prefix
- 233 / VA
- Registered
- 2021-04-02
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-04-02
Registered in v-safe
-
2021-04-02
Dose 1 — Pfizer-BioNTech
- 2021-04-02
-
2021-04-03
Survey response — days 1–6 daily, dose 1MedDRA: Muscular weakness, Pain in extremity — Feeling: Good · DiarrheaFree text: Weakness/Soreness in affected armMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-04-04
- 2021-04-05
- 2021-04-06
- 2021-04-07
- 2021-04-08
- 2021-04-09
-
2021-04-16
Survey response — day 14, dose 1MedDRA: Oligomenorrhoea — Feeling: GoodFree text: Abnormally long (but light flow) menstruation, lasting 12 days to date and currently ongoing.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-23
Dose 2 — Pfizer-BioNTech
-
2021-04-23
Survey response — day 0, dose 2MedDRA: Menstrual disorder — Feeling: Good · Fatigue or tirednessFree text: Menstruation (light flow) lasting just under 3 weeks, beginning soon after 1st dose.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
-
2021-04-24
Health check-in — days 1–6 daily, dose 2Feeling: Fair · Site: Pain · Muscle or body aches, Fatigue or tirednessAdult check-in
- 2021-04-25
- 2021-04-26
- 2021-04-27
- 2021-04-28
- 2021-04-29
- 2021-04-30
-
2021-05-07
Survey response — day 14, dose 2MedDRA: Discharge, Menstruation delayed, Menstruation irregular — Feeling: FairFree text: Ongoing concerns about menstrual cycle- began 4/4 and lasted approximately 3.5 weeks, but unusual (brown-colored) discharge remains present. Also passed an abnormally large blood clot 5/6. Next menstrual cycle has not started.MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-05-14
- 2021-05-21
- 2021-05-28
- 2021-06-04
- 2021-07-23
- 2021-10-22
- 2022-04-23
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-04-02 | Pfizer-BioNTech | |
| 2 | 2021-04-23 | Pfizer-BioNTech |
Free text
Release 6 — days 1–6 daily, dose 1
Systemic reaction (other): Weakness/Soreness in affected arm
Release 7 — day 14, dose 1
Symptoms: Abnormally long (but light flow) menstruation, lasting 12 days to date and currently ongoing.
Release 7 — day 0, dose 2
Systemic reaction (other): Menstruation (light flow) lasting just under 3 weeks, beginning soon after 1st dose.
Release 8 — day 14, dose 2
Symptoms: Ongoing concerns about menstrual cycle- began 4/4 and lasted approximately 3.5 weeks, but unusual (brown-colored) discharge remains present. Also passed an abnormally large blood clot 5/6. Next menstrual cycle has not started.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Discharge | ✓ | ✓ | ✓ |
| SD | Menstruation delayed | ✓ | ✓ | ✓ |
| SD | Menstruation irregular | ✓ | ✓ | ✓ |
| SD | Oligomenorrhoea | ✓ | ✓ | ✓ |
| SRO | Menstrual disorder | ✓ | ✓ | ✓ |
| SRO | Muscular weakness | ✓ | ✓ | ✓ |
| SRO | Pain in extremity | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release